CaMKIV Antibody (YA5113)

CaMKIV (calcium/calmodulin-dependent protein kinase IV) is a calcium-responsive serine/threonine kinase that functions primarily in the nucleus to couple intracellular calcium signals with CRE-dependent transcription programs through phosphorylation of CREB.^[1] Mechanistically, CaMKIV operates within the CaMKK-CaMKIV-CREB signaling axis, where upstream CaMKK activation promotes CREB phosphorylation and transcriptional responses associated with neuronal plasticity and activity-dependent gene expression.^[2][3] Through this pathway, CaMKIV contributes to the regulation of c-Fos expression, late-phase long-term potentiation (L-LTP), and transcriptional processes required for long-term memory consolidation.^[1] In disease-relevant and experimental models, disruption of CaMKIV signaling reduces activity-induced CREB phosphorylation and impairs hippocampus-dependent memory retention without markedly affecting basal synaptic transmission or early LTP, supporting its role in long-term neuronal adaptation.^[1] Compared with the closely related CaMKII family, which participates broadly in synaptic signaling, CaMKIV shows a stronger association with nuclear transcriptional regulation and trophic CREB-dependent gene expression.^[3] This distinction makes CaMKIV a useful experimental target for investigating calcium-dependent transcription, memory-associated signaling networks, and neuroprotective gene programs.^[1][3] For research applications, pharmacological or genetic manipulation of the upstream CaMKK-CaMKIV pathway is commonly used to examine CREB-mediated transcriptional responses and neuronal plasticity mechanisms.^[2][3]